SAPIRSTEIN JAMES enters MARIZYME, INC. with 5K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 9/10/2020ACC: 0001078782-20-000693
DirectorOfficerOther· Interim Chief Executive Office
Since Dec 2018
5K
Baseline shares
100% direct
5K
Direct ownership
1 position
1.22M
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned5K
Total
5K direct5K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5K | Direct |
| Total | 5K | 5K direct |
Derivative Holdings2
Non-Statutory Option to Purchase Common Stock
DirectUnderlying security
Common Stock
Underlying shares
125K
Shares owned
N/A
Exercise price
1.5
Expiration
—
Exercise window
—
Non-Statutory Option to Purchase Common Stock
DirectUnderlying security
Common Stock
Underlying shares
1.09M
Shares owned
N/A
Exercise price
1.01
Expiration
—
Exercise window
—
Total
Underlying
1.22M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Non-Statutory Option to Purchase Common Stock Direct | Common Stock | 1.5 | — | — | 125K | N/A |
| Non-Statutory Option to Purchase Common Stock Direct | Common Stock | 1.01 | — | — | 1.09M | N/A |
| Total | 1.22M | 0.00 | ||||